HF
INBX icon

HRT Financial’s Inhibrx INBX Stock Holding History

HRT Financial’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,783
Closed -$282K – 3237
2025
Q2 		$282K Buy
+19,783
New +$256K ﹤0.01% 1881

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HRT Financial's INBX Position: Q3 2025 in Review

HRT Financial sold out of Inhibrx (INBX) in Q3 2025, closing a stake of 19,783 shares — an estimated $282K sold.

HRT Financial first reported a position in INBX in Q2 2025 and held it in 1 quarter. The position peaked at $282K in Q2 2025. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2025.

  • HRT Financial reported no remaining Inhibrx position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 19,783 Inhibrx shares in Q3 2025, an estimated $282K.
  • HRT Financial first reported a position in Inhibrx in Q2 2025 and held it in 1 quarter.
  • HRT Financial's Inhibrx position peaked at $282K in Q2 2025.
  • 102 funds tracked by Wall St. Rank held Inhibrx as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.